title: Should a protease inhibitor be standard of care for HIV postexposure prophylaxis?
authors.forename: John
authors.initials: J
authors.lastname: McAllister
authors.forename: Andrew
authors.initials: A
authors.lastname: Carr
mesh_terms: D018791:CD4 Lymphocyte Count; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology / Q000517:prevention & control*; D017320:HIV Protease Inhibitors / Q000008:administration & dosage*; D015497:HIV-1 / Q000187:drug effects*; D006801:Humans; D056990:Post-Exposure Prophylaxis; D059039:Standard of Care; D016896:Treatment Outcome
chemical_list: D017320:HIV Protease Inhibitors